Altering molecular mechanisms to prevent sudden arrhythmic death

Lancet

Volumn 351, Issue 9111, 1998, Pages 1276-1278

  Henry, Philip D ^a   Pacifico, Antonio ^a  

^a Texas Arrhythmia Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTIARRHYTHMIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LEUKOTRIENE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PHOSPHOLIPID; PROSTAGLANDIN SYNTHASE INHIBITOR; SIMVASTATIN; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; THROMBOCYTE ACTIVATING FACTOR RECEPTOR;

ATHEROGENESIS; CLINICAL TRIAL; DRUG MECHANISM; DYSLIPIDEMIA; ELECTROPHYSIOLOGY; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; PRIORITY JOURNAL; SHORT SURVEY; SUDDEN DEATH;

EID: 0032565418     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)10049-6     Document Type: Note

References (35)

1. 1 Becker LB. The epidemiology of sudden death. In: Paradis NA, Halperin HR, Nowak RM, eds. Cardiac arrest - the science and practice of resuscitatation medicine. Baltimore, USA: Williams & Wilkins, 1996: 28-47.
2. 2 Fornes P, Lecomte P, Nicolas G. Mort subite extrahospitalière: étude autopsique comparative entre des sujets avec et sans antécédents cardiovasculaires. Arch Mal Coeur 1994; 87: 319-24.
3. 3 The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989; 321: 406-12.
4. 4 Julian DG, Camm AJ, Frangin G, et al, for the European Myocardial Infarct Amiodarone Trial Investigators. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet 1997; 349: 667-74.
5. 5 Cairns JA, Conolly SJ, Roberts R, Gent M, for the Canadian Amiodarone Myocardial Infarction Arhythmia Trial Investigators. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Lancet 1997; 349: 675-82.
6. 6 Waldo AL, Camm AJ, de Ruyter H, for the SWORD investigators. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet 1996; 348: 7-12.
7. 7 Heidenreich PA, Lee TT, Massie BM. Effect of beta-blockade on mortality in patients with heart failure - a meta-analysis of randomized clinical trials. J Am Coll Cardiol 1997; 30: 27-34.
8. 8 Kober L, Torp-Pedersen C, Carlsen JE, et al, for the Trandolapril Cardiac Evaluation study group: a clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1995; 333: 1670-76.
9. 9 Rials SJ, Wu Y, Ford N, et al. Effect of left ventricular hypertrophy and its regression on ventricular electrophysiology and vulnerability to inducible arrhythmia in the feline heart. Circulation 1995; 91: 426-30.
10. 10 Yarnell JWG, Baker IA, Sweetnam PM, et al. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease: the Caerphilly and Speedwell Collaborative Heart Disease Studies. Circulation 1991; 83: 836-44.
11. 2. Arterioscler Thromb Vasc Biol 1995; 15: 1131-38.
12. 12 Jovinge S, Ares MPS, Kallin B, Nilsson J. Human monocytes/macrophages release TNF-α in response to Ox-LDL. Arterioscler Thromb Vasc Biol 1996; 16: 1573-79.
13. 13 Galea J, Armstrong J, Gadsdon P, Holden H, Francis SE, Holt CM. Interleukin-1β in coronary arteries of patients with ischemic heart disease. Arterioscler Thromb Vasc Biol 1996; 16: 1000-06.
14. 14 Yla Hertualla SY, Lipton BA, Rosefeld ME, et al. Expression of monocyte chemotactic protein 1 in monocyte rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci (USA) 1993; 88: 5252-56.
15. 15 Prescott SM, McIntire TM, Zimmerman GA, Stafforini DM. Inflammation as an early component of atherosclerosis and vascular damage - a role for P-selectin and platelet activating factor. Jap Circ J 1996; 60: 137-41.
16. 16 Sakai A, Kume N, Nish E, Tanoue K, Miyasaka M, Kita T. P-selectin and vascular adhesion molecule-1 are focally expressed in aortas of hypercholesterolemic rabbits before intimal accumulation of macrophages and T-lymphocytes. Arterioscler Thromb Vasc Biol 1997; 17: 310-16.
17. 17 Jahan-Vague I, Pyke SDM, Alessi MC, Jespersen J, Haverkate F, Thompson SG, on behalf of the ECAT Study Group. Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. Circulation 1996; 94: 2027-63.
18. 18 Young MR, Matthews JP, Kanabrocki EL, Sothern RB, Roitman-Johnson B, Scheving LE. Circadian rhythmometry of serum interleukin-2, interleukin-10, tumor necrosis factor-alpha, and granulocyte-macrophage colony stimulating factor in men. Chronobiol Internat 1995; 12: 19-27.
19. 19 Kluft C, Jie AFH, Rijken DC, Verheijen JH. Daytime fluctuations in blood tissue-type plasminogen activator (t-PA) and its fast-acting inhibitor (PAI-1). Thromb Haemost 1988; 59: 329-32.
20. 20 Lemberger T, Saladin R, Vázquez M, et al. Expression of peroxisome proliferator-activated receptor α gene is stimulated by stress and follows a diurnal rhythm. J Biol Chem 1996; 271: 1764-69.
21. 21 Zolbe RG, Deedwania PC. Circadian patterns of acute myocardial infarction: role of triggers and other modulating factors. In: Deedwania PC, ed. Circadian rhythms of cardiovascular disorders. Armonk, NY, USA: Futura, 1997: 1-26.
22. 4 pathway to inflammation control. Nature 1996; 384: 39-43.
23. 23 Shiratori Y, Okwu AK, Tabas I. Free cholesterol loading of macrophages stimulates phosphatidylcholine biosynthesis and upregulation of CTP: phosphocholine cytidylyltransferase. J Biol Chem 1994; 269: 11337-48.
24. 24 Asai K, Funaki C, Hayashi T, et al. Dexamethasone-induced suppression of aortic atherosclerosis in cholesterol-fed rabbits. Arterioscler Thromb 1993; 13: 892-99.
25. 25 Hoffman BF, Guo SD, Feinmark SJ. Arrhythmias caused by platelet activating factor. J Cardiovasc Electrophysiol 1996; 7: 120-33.
26. + signaling via the platelet-activating factor receptor in murine peritoneal macrophages. Amer J Physiol (Heart and Circul Physiol) 1997; 272: H17-H24.
27. 27 Jacobsen AN, Du XJ, Lambert KA, Dart AM, Woodcock EA. Arrhythmogenic action of thrombin during myocardial reperfusion via rlease of inositol 1,4,5-triphosphate. Circulation 1996; 93: 23-26.
28. 28 Pedersen T, Kjekshus J, Berg K, et al, for the Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary arter disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 34: 1383-89.
29. 29 Kang JK, Leaf A. Antiarrhythmic effects of polyunsaturated fatty acids. Circulation 1996; 94: 1774-80.
30. 30 Schoonjans K, Staels B, Auwerx J. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J Lipid Res 1996; 36: 907-25.
31. 31 Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973-79.
32. 32 Clària J, Sherhan CN. Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc Natl Acad Sci USA 1995; 92: 9475-79.
33. 33 Tamura K, Kimura Y, Tamura T, et al. The effect of platelet-activating factor antagonist TCV-309 on arrhythmias and functional recovery during myocardial reperfusion. Coron Artery Dis 1994; 5: 267-73.
34. 34 Peraldi P, Hotamisligil GS, Buurman WA, White MF, Spiegelman BM. Tumor necrosis factor (TNF)-alpha inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphyngomyelinase. J Biol Chem 1996; 271: 13018-22.
35. 35 Matsumori A, Ono K, Nishio R, Nose Y, Sasayama S. Amiodarone inhibits production of tumor necrosis factor-α by human mononuclear cells - a posible mechanism for its effects in heart failure. Circulation 1997; 96: 1386-89.